Cerebrolysin

Cerebrolysin is a peptide preparation derived from pig brains. It is often used as a treatment for Alzheimer's disease, stroke, and other neurological disorders.

Composition

Cerebrolysin is composed of free amino acids and low-molecular-weight peptides. The exact composition varies, but it typically includes brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and ciliary neurotrophic factor (CNTF).

Mechanism of Action

Cerebrolysin works by mimicking the action of endogenous neurotrophic factors in the brain. It promotes neuronal survival, neurogenesis, and neuroplasticity, and it also has antioxidant and anti-apoptotic effects.

Clinical Use

Cerebrolysin is used in many countries for the treatment of Alzheimer's disease, stroke, and other neurological disorders. It has been shown to improve cognitive function and quality of life in patients with these conditions.

Side Effects

Common side effects of Cerebrolysin include headache, nausea, dizziness, and insomnia. In rare cases, it can cause allergic reactions.

Research

Research on Cerebrolysin has shown promising results in the treatment of Alzheimer's disease and stroke. However, more studies are needed to confirm its efficacy and safety.

See Also

• Neurotrophic factors
• Alzheimer's disease
• Stroke

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia